Neumora Therapeutics (NMRA) Long-Term Investments (2022 - 2024)

Neumora Therapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $302000.0 for Q1 2024.

• In Q1 2024, Long-Term Investments changed N/A year-over-year to $302000.0; the TTM figure through Mar 2024 stood at $302000.0 (changed N/A YoY), while the FY2023 annual figure was $9.8 million, down 58.13% from the prior year.
• Long-Term Investments for Q1 2024 stood at $302000.0, down from $9.8 million in the prior quarter.
• The five-year high for Long-Term Investments was $23.5 million in Q4 2022, with the low at $302000.0 in Q1 2024.
• The 3-year median for Long-Term Investments is $9.9 million (2023), against an average of $10.9 million.
• Peak annual rise in Long-Term Investments reached 58.13% in 2023, while the deepest fall reached 58.13% in 2023.
• Neumora Therapeutics' Long-Term Investments stood at $23.5 million in 2022, then sank by 58.13% to $9.8 million in 2023, then plunged by 96.93% to $302000.0 in 2024.
• Business Quant data shows NMRA's Long-Term Investments at $302000.0 in Q1 2024, $9.8 million in Q4 2023, and $9.9 million in Q3 2023.